Uso de pruebas de diagnóstico rápido de detección de antígenos del SARS-CoV-2 para el autodiagnóstico de la COVID-19: orientaciones provisionales, 9 de marzo de 2022: anexo A de la web: cuadro GRADE: ¿debería ofrecerse la prueba de autodiagnóstico de la COVID-19 mediante PDR-Ag del SARS-CoV-2 como método adicional?
Ginebra; Organización Mundial de la Salud; 2022. (WHO/2019-nCoV/Ag-RDTs/Self_testing/Web_annex_A/2022.1).
in Spanish
| WHO IRIS
| ID: who-352907
Responsible library:
CH1.1
Full text:
Available
Collection:
Databases of international organizations
Health context:
Sustainable Health Agenda for the Americas
Health problem:
Goal 8: Outbreaks, emergencies and disasters
Database:
WHO IRIS
Main subject:
Reagent Kits, Diagnostic
/
Disease Outbreaks
/
Sensitivity and Specificity
/
Guidelines as Topic
/
Diagnostic Tests, Routine
/
Betacoronavirus
/
Self-Testing
/
COVID-19 Testing
/
COVID-19
Type of study:
Diagnostic study
/
Practice guideline
Language:
Spanish
Year:
2022